Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson's Disease?

Leal MC, Casabona JC, Puntel M, Pitossi FJ

Open source

DOI
10.3389/fncel.2013.00053
Published
2013
Container
Frontiers in cellular neuroscience
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fncel.2013.00053,
  title = {Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson's Disease?},
  author = {Leal MC and Casabona JC and Puntel M and Pitossi FJ},
  year = {2013},
  journal = {Frontiers in cellular neuroscience},
  doi = {10.3389/fncel.2013.00053},
  url = {https://doi.org/10.3389/fncel.2013.00053}
}

RIS

TY  - JOUR
TI  - Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson's Disease?
AU  - Leal MC
AU  - Casabona JC
AU  - Puntel M
AU  - Pitossi FJ
PY  - 2013
JO  - Frontiers in cellular neuroscience
DO  - 10.3389/fncel.2013.00053
UR  - https://doi.org/10.3389/fncel.2013.00053
ER  - 

APA

MC, L., JC, C., M, P., & FJ, P. (2013). Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson's Disease?. Frontiers in cellular neuroscience. https://doi.org/10.3389/fncel.2013.00053

Source records